Related Experiment Video
Updated: Jul 4, 2026
In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones
Published on: July 25, 2019
Ubiquitin-independent degradation of proteins by the proteasome
Isabelle Jariel-Encontre1, Guillaume Bossis, Marc Piechaczyk
1Institut de Génétique Moléculaire de Montpellier, CNRS, UMR5535, IFR122, 1919 Route de Mende, Montpellier, F-34293, France.
Abstract:
The proteasome is the main proteolytic machinery of the cell and constitutes a recognized drugable target, in particular for treating cancer. It is involved in the elimination of misfolded, altered or aged proteins as well as in the generation of antigenic peptides presented by MHC class I molecules. It is also responsible for the proteolytic maturation of diverse polypeptide precursors and for the spatial and temporal regulation of the degradation of many key cell regulators whose destruction is necessary for progression through essential processes, such as cell division, differentiation and, more generally, adaptation to environmental signals. It is generally believed that proteins must undergo prior modification by polyubiquitin chains to be addressed to, and recognized by, the proteasome. In reality, however, there is accumulating evidence that ubiquitin-independent proteasomal degradation may have been largely underestimated. In particular, a number of proto-oncoproteins and oncosuppressive proteins are privileged ubiquitin-independent proteasomal substrates, the altered degradation of which may have tumorigenic consequences. The identification of ubiquitin-independent mechanisms for proteasomal degradation also poses the paramount question of the multiplicity of catabolic pathways targeting each protein substrate. As this may help design novel therapeutic strategies, the underlying mechanisms are critically reviewed here.
Insights
The proteasome degrades proteins, crucial for cell regulation and cancer treatment. Emerging evidence shows ubiquitin-independent degradation is vital, impacting cancer and offering new therapeutic strategies.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- The proteasome is a key cellular machine for protein degradation, essential for regulating cell processes and a target for cancer therapy.
- While protein degradation by the proteasome is often linked to ubiquitin chains, ubiquitin-independent pathways are increasingly recognized.
- Dysregulation of proteasomal degradation, particularly of oncoproteins, can lead to cancer development.
Purpose of the Study:
- To review the mechanisms of ubiquitin-independent proteasomal degradation.
- To highlight the significance of these pathways in cellular regulation and disease.
- To explore the implications for novel therapeutic strategies in cancer treatment.
Main Methods:
- Literature review of existing research on proteasomal degradation.
- Analysis of studies investigating ubiquitin-independent protein targeting.
- Synthesis of findings related to cancer-associated proteins and proteasomal pathways.
Main Results:
- Accumulating evidence suggests ubiquitin-independent proteasomal degradation is more prevalent than previously thought.
- Certain proto-oncoproteins and tumor suppressors are degraded via ubiquitin-independent mechanisms.
- This highlights the complexity of protein catabolism and raises questions about substrate specificity.
Conclusions:
- Ubiquitin-independent proteasomal degradation plays a critical, yet underestimated, role in cellular homeostasis.
- Understanding these pathways is crucial for comprehending tumorigenesis and developing targeted cancer therapies.
- Further research into the multiplicity of protein degradation routes can inform novel therapeutic approaches.
Related Concept Videos
01:13The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
02:18The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
02:18The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
02:58Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
02:58Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
01:17The Proteasome Structure
The proteasome is an...